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Abstract
Laboratory testing is the single highest-volume medical activity, making it useful to ask how well one can anticipate
whether a given test result will be high, low, or within the reference interval (‘‘normal’’). We analyzed 10 years of electronic
health records—a total of 69.4 million blood tests—to see how well standard rule-mining techniques can anticipate test
results based on patient age and gender, recent diagnoses, and recent laboratory test results. We evaluated rules according
to their positive and negative predictive value (PPV and NPV) and area under the receiver-operator characteristic curve (ROC
AUCs). Using a stringent cutoff of PPV and/or NPV$0.95, standard techniques yield few rules for sendout tests but several
for in-house tests, mostly for repeat laboratory tests that are part of the complete blood count and basic metabolic panel.
Most rules were clinically and pathophysiologically plausible, and several seemed clinically useful for informing pre-test
probability of a given result. But overall, rules were unlikely to be able to function as a general substitute for actually
ordering a test. Improving laboratory utilization will likely require different input data and/or alternative methods.
Citation: Mohammad F, Theisen-Toupal JC, Arnaout R (2014) Advantages and Limitations of Anticipating Laboratory Test Results from Regression- and Tree-
Based Rules Derived from Electronic Health-Record Data. PLoS ONE 9(4): e92199. doi:10.1371/journal.pone.0092199
Editor: Pal Bela Szecsi, Gentofte University Hospital, Denmark
Received November 24, 2013; Accepted February 19, 2014; Published April 14, 2014
Copyright:  2014 Mohammad et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: The authors have no support or funding to report.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: rarnaout@bidmc.harvard.edu
Introduction
Laboratory testing is the single highest-volume medical activity
[1]. Its main role is to help adjust the level of clinical suspicion of a
diagnosis to help rule it in or out; it is also used for disease
monitoring. In practice, the level of clinical suspicion and the
probability of a given test result can be correlated: the higher the
suspicion, the more likely it is that the result will confirm the
diagnosis. Information that feeds into the clinical suspicion—
including the age and gender of the patient, prior diagnoses, and
prior laboratory results—thus may also influence the test result.
In principle, this relationship can be used to improve laboratory
testing by making it possible to estimate the pre-test probability of
getting a given test result before ordering the test, and, in the limit,
to reduce test utilization without adversely affecting patient
outcomes. Indeed, ordering fewer tests, where warranted, might
benefit outcomes by saving the patient the burden of following up
false positives (or negatives) [2–4].
Conceptually, the relationship between clinical suspicion and
pre-test probability is used routinely to help set guidelines
regarding when and when not to order a given test. For example,
the pre-test probability of Lyme serology being positive given a
targetoid rash is high enough that, given the test’s sensitivity and
specificity, ordering the test is contraindicated [5]. Because of the
large number of tests and clinical scenarios that exist, and in light
of evidence from across medicine that utilization of laboratory
testing can be improved [1,6], it is of interest to understand
whether analyzing large clinical databases using the robust
application of standard statistical techniques can turn this
relationship into actionable decision-support rules—or whether
progress toward better laboratory utilization might instead lie
elsewhere.
We sought to test the limits of rule-mining for this purpose. To
what extent can laboratory results be anticipated computationally
based on data available to the clinician, or a clinical decision
support system, at the time of the order? We addressed this
question using generalized linear modeling (GLM), a generalized
form of linear regression [7], and, for comparison, classification
trees (CT) [8,9].
Methods
We used four types of input—age, gender, diagnoses (three-digit
ICD-9 codes), and results of laboratory tests on blood samples
added to the record in the seven days before a given test was
ordered—to build simple, robust models for whether the result of a
test would be within the reference interval (‘‘normal’’) or outside of
it in a given direction (‘‘abnormal’’), treating high and low results
separately.
We based our study on 10 years of records from the Beth Israel
Deaconess Medical Center (BIDMC), a 585-bed tertiary care
center in Boston, MA. We first anonymized records and
reconciled test names (work approved by BIDMC Committee
on Clinical Investigation’s Institutional Review Board for
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01). Informed consent was not obtained because patient records/
information was anonymized prior to analysis. Each blood test (the
test of interest), over 69.4 million in all, was marked as an in-house
test (performed at the hospital) or a sendout (performed off-site).
For each test, we compiled a list of all instances in which the test
was ordered and performed. For each instance, we recorded the
patient’s age, gender, and any diagnoses or other blood-test test
results from the seven days prior to the result of interest. When a
test was ordered multiple times within a seven-day period, we
considered only the most recent one (i.e., the one closest in time to
the sendout order) as input data. For relevance, we considered
only those tests that were ordered at least 1,000 times over the
entire 10-year period, for an average of at least twice a week. We
randomly divided the resulting instances into a training set and a
test set (see below for details).
All tests had either two (reference vs. abnormal) or three (low,
normal, or high) possible response values. For tests with three
values, we performed two separate rule searches: one for high vs.
not high—i.e., grouping normal and low—and one for low vs. not
low.
Generalized linear modeling (GLM)
We sought to identify simple, robust subsets of our input data to
evaluate as linear predictors (‘‘rules’’) for whether a test result
would be normal or abnormal. To do this, we used GLM twice:
first to find rules based on a particular training set and a second
time to find rules based on just those items that were common to
rules found from a number of different training sets (to avoid
overfitting any one training set). We did this as follows, for each
test of interest (the response variable or ‘‘response’’).
We first excluded those input variables (‘‘features’’) that
appeared with fewer than 5 percent of the response. We then
temporarily set aside the most common features (those of the
complete blood count and basic metabolic panel) as well as age
and gender, and searched the remaining items for frequent
featuresets (using the Apriori algorithm [10,11]). We then added
back to each resulting featureset the common features, age, and
gender (which are frequent items by definition, since they appear
in all instances) with a support threshold of 0.60 (i.e., itemsets for
which all items were present with at least 60 percent of instances of
the response variable). This set-aside/add-back approach sped the
search for featuresets without loss of comprehensiveness.
We used each featureset to create a model for the test of interest
using R’s glm function (with the family argument set to
‘‘Binomial’’). We used backward feature elimination to remove
non-significant features one at a time from the featureset (using a
significance threshold p-value of 1610
25; see below) until the only
features that remained were all significantly correlated with the
response. We also removed features that are used to calculate the
result for the test of interest—e.g., CD4 and CD8 count for T-cell
count, which is the sum of CD4 and CD8—for all but proof-of-
principle runs.
The significance threshold was corrected for multiple compar-
isons by dividing the traditional threshold of p=0.05 by the
product of the total number of tests considered and the average
number of rules generated for each test. The combined total
number of features (in-house tests plus sendout tests plus diagnoses)
was 170+81+434=685. The average number of rules after
application of GLM for the first time for each test is 6. Thus




We constructed a model for the result by running glm a second
time on a training set (see below) based on this reduced featureset.
Of note, there was no guarantee that any feature would be
significantly correlated (p#1610
25) or that there would be enough
instances (glm’s threshold was 200) of the test appearing with all
features of even the reduced featureset for glm to produce a model.
When feature elimination resulted in no significant features or too
few instances, no model was constructed. We scored models using
PPV, NPV, and ROC AUC.
We were interested only in models that were robust to the size
and choice of training set. Therefore we repeated the above
process for a range of training set-test set splits (80-20, 70-30, 60-
40, 50-50, 40-60, 30-70, and 20-80 percent). For each split, we ran
the above process 10 times and found the number of rules with
AUC$0.75. We decided on using a 60-40 split for downstream
analyses as this split generated a total number of rules comparable
to 70-30 and 80-20 splits but with less training data (Fig. 1).
Finally, for each test of interest, we selected features that
appeared in a strict majority of rules for that test and reran glm
using only those features. This made rules both simpler and more
robust by removing features whose presence was contingent on a
particular choice of training or test set.
Classification and Regression Trees (CART)
For each of the inhouse and sendout tests we used CART,
implemented as RPART in R (rpart v3.1-50; CRAN.R-project.org/
package=rpart), to predict the response from all input features,
using 60:40 training:test-set splits. We fixed some of the metrics
(see below) that were used in building the final tree. The CART
grows classification tree in two stages. In stage one, a tree is grown
by finding a feature which best splits the data into two groups.
Splitting is done only if the overall ‘‘impurity,’’ the number of
outcomes different from the majority (e.g., a ‘‘low’’ response
alongside many ‘‘normal’’ responses), decreases, above some
threshold (the ‘‘complexity parameter;’’ 0.01). Then, in top-down
fashion, these two subgroups are further divided in a recursive
manner until the subgroups reach a minimum size (minsplit=20
records) or until no further improvement can be made. The
resulting tree may overfit the training data. To avoid this, cross-
validation (xval=10; 10-fold cross-validation) was used in the
second stage by pruning the tree. We fixed the maximum depth
(maxdepth) of the tree, i.e., the maximum number of branchings
from stem to leaf, to be 20. The final models were tested on the test
data and performance statistics are found. We repeated model-
building 10 times for each test and summarized the statistics.
Data-processing was performed in Python (Enthought Canopy
Python version 2.7.3. R (version 2.15.3) was used for statistical
analysis and reports generation.
Results
To determine how well sendout and in-house test results can be
anticipated based on basic information available in the medical
record, we used two independent methods—generalized linear
modeling (GLM) and classification and regression trees (CART)—
to build simple, robust test-result predictors and then evaluated the
performance of these predictors according to the standard clinical
metrics of positive predictive value (PPV) and negative predictive
value (NPV), as well as sensitivity and specificity via the receiver-
operator curve (ROC) area under the curve (AUC).
As proof of principle for GLM, we first tested it on the anion
gap, a result calculated by subtracting the serum concentrations of
the anions chloride and bicarbonate from those of the cations
sodium and potassium, and confirmed that our methods found a
rule for elevated anion gap based on these four items.
Anticipating Lab Test Results by Machine Learning
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our hospital. GLM generated rules for just 11 of these tests. For
the remaining tests, either no recent diagnosis or in-house test
result (or age or gender) was sufficiently correlated with the
sendout test result, or there were not enough instances in which
correlated items appeared with the result, to generate a rule. Only
two tests—for high corticotropin (ACTH) and for low ceruloplas-
min—had NPV$0.95. Of these, ceruloplasmin had a PPV$0.94.
The mean AUC for all rules was 0.69, with models for only three
tests having an average AUC$0.75 over 10 repeat runs. Removal
of features that did not appear in a majority of rules had essentially
no effect on these AUCs (difference in mean AUC#0.02).
CART generated rules for 60 tests. However, the AUC for most
of these rules was low, with only five tests having AUC$0.75: free
T3, alpha-macroglobulin, CA27-29, hyaluronic acid, and alpha
fetoprotein (AUC 0.75–0.79).
We next applied GLM to in-house tests. A total of 170 in-house
tests were analyzed. A number of rules exhibited a high PPV (the
probability of seeing an abnormal value given a prediction of an
abnormal value by the rule) or NPV (the probability of seeing a
normal value given prediction of a normal value). These were
mostly components of the complete blood count (CBC) and
metabolic panels. Interestingly, the predictive power of these rules
was almost exclusively based on a previous measurement of the
test in question: in other words, the best rules were for repeat tests,
and the best predictor of a result being normal or abnormal was
whether it had been normal or abnormal within the previous seven
days. For example, the NPV for a low red blood cell count was
0.95 (with PPV=0.75), with a rule that depended most on the
previous red blood cell count also having been low, and the PPV
for high total calcium was 0.98 (NPV=0.76) and based exclusively
on the previous total calcium having been high.
For comparison, we applied CART to in-house tests, again
including in the input data the most recent result for that test if
performed within a week of the order. Again, a number of rules
exhibited a high PPV ($0.95), and again these were often tests of
the CBC and metabolic panels, with rules based almost exclusively
on a previous abnormal value. Examples included low white blood
cell count (WBC; PPV=0.97, NPV=0.79), platelet count (0.95,
0.88), and serum sodium (0.96, 0.65), and high total calcium (0.99,
0.67), mean corpuscular volume (0.98, 0.84), and iron (0.97, 0.56)
all of which were determined almost exclusively from the previous
value being low or high (Table 1). Overall, there was good
agreement in PPV between GLM and CART for tests for which
both methods found rules, but CART outperformed GLM
noticeably in NPV (Fig. 2).
Discussion
The growing availability of large clinical databases has raised
interest in the possibility of using systematic rule-mining for
clinical decision support [12–15]. One popular and well charac-
terized approach has been logistic regression [16–18], a special
case of generalized linear modeling (GLM). Researchers have
applied these approaches for diverse health-related purposes
including prediction of cardiovascular risk [19], mortality in head
trauma [18], texture analysis of magnetic resonance images [16],
and many other applications [17,20,21]. However, we note that
GLM does not easily incorporate missing values, as it removes
records with missing features; a feature will be ‘‘missing’’ for any
record in which that test (the feature) was not performed.
Other methods, such as classification and regression trees
(CART) and artificial neural networks [18], have also been
applied. Most of these studies were limited in scope to predicting
risk of a particular diagnosis. Harper [22] compared four
classification techniques (regression, CART, artificial neural
networks, and discriminant analysis) on four different datasets
and concluded that there was no obvious best choice for their data;
while CART performed best, regression was fastest and nearly as
good. Similar comparative studies on coronary artery disease [20]
and Alzheimer disease [23] indicated that newer algorithms such
as ANN and random forests [24] have little advantage over
simpler, more traditional approaches. Also, the utility and
limitations of these approaches for predicting laboratory results
(as opposed to diagnoses) are unclear. However, while CART is
both a top performer and overcomes GLM’s problem with missing
values, it is also more computationally intensive and potentially
less sensitive to simple algebraic relationships among features (e.g.,
among sodium, chloride and bicarbonate and the anion gap).
Therefore we chose GLM as a well-understood approach with
strong performance and excellent speed, and CART as the best-
performing complementary approach for purposes of comparison.
Given the importance of laboratory testing, we asked how much
information regression- or classification tree-based rules could
provide in assessing the pre-test probability of a test result being
abnormal for 251 commonly ordered in-house and sendout tests at
our hospital.
Data-mining can sometimes find spurious correlations, artifacts
of the particular partitioning of the data into training and test set.
To avoid such artifacts, we repeated our regression on multiple
Figure 1. Performance as a function of training set-test set split. A 60-40 split generated a total number of rules comparable to 70-30 and 80-
20 splits but with less training data.
doi:10.1371/journal.pone.0092199.g001
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appeared in a majority of the resulting rules. This safeguard also
had the effect of simplifying rules by making each rule dependent
on a smaller number of items. As expected, the effect on
performance was negligible and dependence on the resulting
items was more often clinically and pathophysiologically plausible
than rules derived from each run.
When data-mining it is also important to consider the setting.
The rules we found do not exist in a vacuum but are ‘‘contingent’’
in the sense that they depend on current clinical practice. Certain
tests and panels are ordered in patterns. In a sense, contingency is
a form of selection bias: there may well be other diagnoses or test
result results that correlate with the result for the test of interest
that are not routinely measured according to current best
practices. However, as long as the setting in which such rules
would be applied is the substantially similar to that in which they
were found, selection bias would have little if any effect on finding
rules. As long as one is clear that one is looking for relationships in
a current practice process, and not among all things that could
possibly be measured, any rules that are discovered will by
construction be setting-appropriate.
But while our rules appear to be plausible and setting-
appropriate, the motivating question behind this study is whether
the rules we found could be useful clinically. One way to approach
Table 1. PPV, NPV, and key predictors for selected tests.
GLM
Test PPV NPV Key predictors
high anion gap 0.98 0.58 anion gap
high Bicarbonate 0.95 0.76 bicarbonate, creatinine, heart failure
high total calcium 0.99 0.73 total calcium
high MCV 0.98 0.90 MCV
high potassium 0.97 0.32 potassium
low alkaline phosphatase 0.99 0.79 alkaline phosphatase
low MCV 0.99 0.84 MCV
low potassium 0.96 0.32 potassium
low BUN 0.98 0.74 gender, BUN
low WBC 0.96 0.84 WBC
CART
Test PPV NPV Key predictors
high anion gap 0.98 0.64 anion gap
high bicarbonate 0.95 0.79 bicarbonate
high total calcium 0.99 0.67 total calcium
high RDW 0.95 0.95 RDW
high sodium 0.98 0.65 sodium
high free T4 0.95 0.80 free T4
high transferrin 0.98 0.39 transferrin
high anti-cardiolipin IgG 0.95 0.50 thrombin, PTT, WBC
high free T3 0.96 0.85 free T4
high prealbumin 0.99 1.00 albumin, PLT
high SSM antibody 0.96 0.50 C3, age
high SSA antibody 0.98 0.50 rheumatoid factor, diffuse diseases of connective tissue
low chloride 0.96 0.68 chloride
low cortisol 0.96 0.50 cortisol, age, PTT
low MCV 0.99 0.85 MCV
low PTH 0.96 0.57 PTH, total calcium, age
low sodium 0.95 0.72 sodium
low WBC 0.96 0.83 WBC
low alpha-1 antitrypsin 0.99 0.00 iron, AST
low ceruloplasmin 0.96 0.62 transferrin, INR, WBC
low erythropoietin 0.97 0.64 RBC, PLT, lymphocytes, HCT
low 1,25 vitamin D 0.98 0.14 creatinine, PTH, RBC
The most important key predictors are shown; specifically, those that accounted for at least two-thirds of the predictive power of the rule. Abbreviations: BUN, blood
urea nitrogen; HCT, hematocrit; INR, international normalized ratio; MCV, mean corpuscular volume; PTT, partial thromboplastin time; PLT, platelet count; PTH,
parathyroid hormone; RBC, red blood cell count; WBC, white blood cell count.
doi:10.1371/journal.pone.0092199.t001
Anticipating Lab Test Results by Machine Learning
PLOS ONE | www.plosone.org 4 April 2014 | Volume 9 | Issue 4 | e92199this question is by considering the positive and negative predictive
value of each rule (PPV and NPV). These metrics are in contrast to
sensitivity and specificity, by which rules are often measured but
which do not incorporate disease prevalence in spite of its
importance to clinical decision-making. A PPV of 0.95 means that
when a rule suggests that the test result will be abnormal, the result
actually will be abnormal 95 percent of the time. A NPV of 0.95
means that when a rule suggests that the test result will be normal,
the result actually will be normal 95 percent of the time.
We found rules with PPV and/or NPV$0.95 (by GLM) for
only two tests that are sendouts at our hospital—one of which is
ceruloplasmin, which we have previously suggested is overordered
via chart review [25]. In contrast, for in-house tests we found over
a dozen such rules. Interestingly, the main determinant for rules
for in-house tests was a normal or abnormal result for the same test
within the previous seven days. Although in this study we did not
set out explicitly to make a statement about repeat laboratory
testing, the appropriateness of which has been investigated
elsewhere [4], these results suggest that repeat laboratory testing
within one week does not always add information that could not
have been anticipated from the previous result. Refining this
observation using the same unbiased approach we have followed
here is potentially an area for future investigation.
Our results should not be taken as a categorical criticism of
repeat testing. First, while the PPV was $0.95 in several cases, the
NPV was more typically 0.70–0.85. Thus, while prediction that a
result will be abnormal may be correct 95 percent of the time,
which may be good enough to discourage repeat ordering,
prediction that a result will be normal may not be so dependable.
Therefore use of a rule depends on the subtle distinction of
whether the clinical question is ‘‘will the result be abnormal’’ vs.
‘‘will the result be normal.’’ Second, we note that no rules with
such strong performance were found for the majority of our
sendout or in-house tests by either of our two complementary
approaches. Thus while the rules we found can inform clinical
decision-makers, the information they provide rarely replaces the
information obtained from actually performing these tests.
It is interesting to note that on average, our simple rules yielded
a PPV of 0.84 and an NPV of 0.75. This means that on average,
rules will correctly predict an abnormal laboratory result 5 times
out of 6 (5/6<0.84) and correctly predict a normal result 3 times
out of 4. While not good enough to replace testing (especially for
rules that depend on previous test results), these observations raise
the question of how much better prediction can get. Integration of
information not considered in the present study, including vital
signs, chief complaints, and physical findings, may improve
prediction by these methods.
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Figure 2. PPV and NPV for the same test, GLM vs. CART. Both linear modeling (GLM) and classification trees (CART) were better at finding rules
with high positive predictive value (PPV; panels a and b), with good agreement between the methods, than negative predictive value (PPV; panels c
and d).
doi:10.1371/journal.pone.0092199.g002
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